Funds/Sectoral / Thematic/ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

ICICI Prudential Mutual Fund·Sectoral / Thematic·vs Nifty 500 TRI

The fund remains heavily tilted toward large-cap pharma leaders like Sun, Cipla, and Dr. Reddy's, with the top five commanding nearly 40 percent—typical of a thematic play betting on India's pharmaceutical export dominance and domestic consumption growth. The manager's recent moves—exiting Treasury bills, adding Abbott for healthcare services diversification, and trimming Aurobindo while boosting Cohance—suggest conviction in specialty and CDMO players over commodity generics, reflecting confidence in margin expansion and value-addition opportunities in the sector.

Portfolio analysis · April 2026

NAV & Returns

Plan	NAV	1M	3M	6M	1Y	3Y CAGR	5Y CAGR
Primary	₹23.9700	+8.95%	+8.61%	+0.93%	+0.00%	+17.17%	+6.04%

Returns above 1Y are CAGR. Direct plan rows highlighted. NAV from AMFI.

Portfolio Metrics(latest month)

Holdings

Top 5 Weight

39.50%

Top 10 Weight

60.16%

Active Share

—

Large Cap

31.92%

Gini

0.469

What Changed2026-03-31 → 2026-04-30

Holdings: 42 → 41+1 added−2 removed29 weight shifts ≥ 0.1%

Stock	Sector	Weight
Abbott India Ltd.	Pharmaceuticals & Biotechnology	1.88%

Full Holdings

#	Holding	Sector	Class	% to NAV
1	Sun Pharmaceutical Industries Ltd. INE044A01036	Pharmaceuticals & Biotechnology	EQUITY	11.76%
2	Cipla Ltd. INE059A01026	Pharmaceuticals & Biotechnology	EQUITY	8.15%
3	Mankind Pharma Ltd. INE634S01028	Pharmaceuticals & Biotechnology	EQUITY	7.58%
4	Divi's Laboratories Ltd. INE361B01024	Pharmaceuticals & Biotechnology	EQUITY	6.06%
5	Dr. Reddy's Laboratories Ltd. INE089A01031	Pharmaceuticals & Biotechnology	EQUITY	5.94%
6	Biocon Ltd. INE376G01013	Pharmaceuticals & Biotechnology	EQUITY	5.81%
7	Cohance Lifesciences Ltd. INE03QK01018	Pharmaceuticals & Biotechnology	EQUITY	4.44%
8	Lupin Ltd. INE326A01037	Pharmaceuticals & Biotechnology	EQUITY	3.80%
9	Medplus Health Services Ltd INE804L01022	Retailing	EQUITY	3.37%
10	Alkem Laboratories Ltd. INE540L01014	Pharmaceuticals & Biotechnology	EQUITY	3.24%
11	Syngene International Ltd. INE398R01022	Healthcare Services	EQUITY	3.09%
12	TREPS		CASH_EQUIVALENT	2.19%
13	Akums Drugs and Pharmaceuticals Ltd. INE09XN01023	Pharmaceuticals & Biotechnology	EQUITY	2.02%
14	Pfizer Ltd. INE182A01018	Pharmaceuticals & Biotechnology	EQUITY	1.96%
15	Aurobindo Pharma Ltd. INE406A01037	Pharmaceuticals & Biotechnology	EQUITY	1.93%
16	Abbott India Ltd. INE358A01014	Pharmaceuticals & Biotechnology	EQUITY	1.88%
17	Thyrocare Technologies Ltd. INE594H01019	Healthcare Services	EQUITY	1.88%
18	J.B.Chemicals & Pharmaceuticals Ltd. INE572A01036	Pharmaceuticals & Biotechnology	EQUITY	1.77%
19	Alembic Pharmaceuticals Ltd. INE901L01018	Pharmaceuticals & Biotechnology	EQUITY	1.74%
20	Alivus Life Sciences Ltd. INE03Q201024	Pharmaceuticals & Biotechnology	EQUITY	1.72%

Sector Allocation

Pharmaceuticals & Biotechnology81.9%

Healthcare Services6.7%

Retailing5.1%

Insurance1.3%

Chemicals & Petrochemicals1.1%

Healthcare Equipment & Supplies0.7%

Top 10 sectors by % to NAV. Excludes derivatives.